Adverse events (AE) | Â | Nitroxoline | Controls |
---|---|---|---|
 | Patients (total) | 234 (100%) | 232 (100%) |
 | Patients with AEs# | 23 (9.8%) | 18 (7.8%) |
Adverse events (total) | Â | 33 | 26 |
Nervous system disorders | Headache | 3 | 4 |
 | Dizziness | - | 3 |
Eye disorders | Eyelid swelling | 1 | - |
Cardiac and circulation disorders | Circulation disorder | - | 1 |
Gastrointestinal disorders | Dysgeusia | - | 1 |
 | Nausea | 9 | 3 |
 | Regurgitation | 1 | 1 |
 | Gastralgia | 4 | 3 |
 | Obstipation | - | 1 |
 | Diarrhoea | 5 | - |
Metabolim and nutrition disorder | Anorexia | 1 | - |
Urinary disorders | Incontinence | 1 | - |
Reproductive system disorders | Colpitis | 1 | 1 |
 | Fluor vaginalis | 1 | - |
 | Tubal tumor | - | 1 |
Immune system disorders | Allergy | 1* | 1 |
Skin and subcutaneous tissue disorders | Itching | 1 | 1 |
 | Urticaria | 1 | 1 |
 | Herpes labialis | - | 1 |
General disorders | Intolerance | 1 | - |
 | Weakness | 1 | - |
 | Fever | 1 | - |
Musculoskeletal, connective tissue and bone disorders | Back pain | - | 1 |
 | Flank pain | - | 2 |
 | Leg pain | - | 1 |